Completed
Led by National Institute on Drug Abuse (NIDA) · Updated on 2005-08-17
N/A
Participants Needed
1
Research Sites
N/A
Total Duration
N
National Institute on Drug Abuse (NIDA)
Lead Sponsor
U
University of Vermont
Collaborating Sponsor
The purpose of this study is to evaluate buprenorphine and behavioral treatment with and without contingent payment on compliance with pro-social activities. In addition, we will examine whether blind naltrexone dosing is effective in indicating naltrexone consumption.
CONDITIONS
Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13
You may qualify if you...
Please contact site for information.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Total: 1 location
1
Treatment Research Center
Burlington, Vermont, United States, 05401
Status Unknown
Study Type
INTERVENTIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
TREATMENT
Number of Arms
0
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Kristine I Bunyoz, Georgios Tsikandylakis, Kristian Mortensen...
https://pubmed.ncbi.nlm.nih.gov/34102902